Topical corticosteroid application and the structural and functional integrity of the epidermal barrier
- PMID: 24307921
- PMCID: PMC3848648
Topical corticosteroid application and the structural and functional integrity of the epidermal barrier
Abstract
Topical corticosteroids are a very important part of the treatment of many skin disorders, especially eczematous dermatoses. When utilized properly and judiciously these agents often achieve excellent results in clearing or markedly improving many dermatological disorders. As some studies have shown, topical corticosteroids, despite their ability to decrease inflammation through several mechanisms, induce abnormalities in lipid synthesis and intercellular bilayer structure in the stratum corneum, which appear to prolong epidermal barrier recovery. These adverse effects may contribute to eariier eczematous flaring if measures to provide barrier repair are not undertaken. In addition, although topical corticosteroids are applied only to sites affected by the skin eruption, the incorporation of "barrier friendly" excipients into the vehicle that improve stratum corneum permeability barrier function and integrity is very rational.
Similar articles
-
Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.J Invest Dermatol. 2003 Mar;120(3):456-64. doi: 10.1046/j.1523-1747.2003.12053.x. J Invest Dermatol. 2003. PMID: 12603860
-
A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.J Clin Aesthet Dermatol. 2012 Jul;5(7):20-4. J Clin Aesthet Dermatol. 2012. PMID: 22798972 Free PMC article.
-
A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.J Drugs Dermatol. 2014 May;13(5):582-5. J Drugs Dermatol. 2014. PMID: 24809882 Clinical Trial.
-
Barrier function of the skin: "la raison d'être" of the epidermis.J Invest Dermatol. 2003 Aug;121(2):231-41. doi: 10.1046/j.1523-1747.2003.12359.x. J Invest Dermatol. 2003. PMID: 12880413 Review.
-
Barrier function regulates epidermal lipid and DNA synthesis.Br J Dermatol. 1993 May;128(5):473-82. doi: 10.1111/j.1365-2133.1993.tb00222.x. Br J Dermatol. 1993. PMID: 8504036 Review.
Cited by
-
Impetigo Incognito - A Case Series of Steroid Modified Impetigo.Indian Dermatol Online J. 2023 Jul 25;14(6):898-900. doi: 10.4103/idoj.idoj_677_22. eCollection 2023 Nov-Dec. Indian Dermatol Online J. 2023. PMID: 38099020 Free PMC article. No abstract available.
-
Assessment of Cosmetic and Dermatological Properties and Safety of Use of Model Skin Tonics with Kombucha-Fermented Red Berry Extracts.Int J Mol Sci. 2022 Nov 24;23(23):14675. doi: 10.3390/ijms232314675. Int J Mol Sci. 2022. PMID: 36499003 Free PMC article.
-
A new avenue for treatment of chronic hand eczema.Br J Dermatol. 2022 Jul;187(1):7-8. doi: 10.1111/bjd.21604. Epub 2022 May 1. Br J Dermatol. 2022. PMID: 35490378 Free PMC article.
-
Antidermatophyte activity and PK/PD of ME1111 in a guinea pig model of tinea corporis.J Antibiot (Tokyo). 2024 Aug;77(8):533-539. doi: 10.1038/s41429-024-00738-y. Epub 2024 May 20. J Antibiot (Tokyo). 2024. PMID: 38769156
-
Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Task Force against Recalcitrant Tinea (ITART) Consensus on the Management of Glabrous Tinea (INTACT).Indian Dermatol Online J. 2020 Jul 13;11(4):502-519. doi: 10.4103/idoj.IDOJ_233_20. eCollection 2020 Jul-Aug. Indian Dermatol Online J. 2020. PMID: 32832435 Free PMC article.
References
-
- Hengge UR. Topical corticosteroids. In: Gaspari AA, Tyring SK, editors. Clinical and Basic Immunodermatohgy. London: Springer-Verlag; 2008. pp. 561–577.
-
- Warner MR, Camisa C. Topical immunomodulatory and antiproliferative drugs: topical corticosteroids. Wolverton S, editor. Comprehensive Dermatohgix; Drug Therapy: Expert Consult. Online and print. 3rd ed. Edinburgh: Saunders/Elsevier; 2013: 487-504.
-
- Del Rosso J, Friedlander SF. Corticosteroids: options in the era of steroid-sparing therapy. J Am Acad Dermatol. 2005;53:850–858. - PubMed
-
- Sulzberger MB, Witten VH. Effect of topically applied compound Ғ in selected dermatoses. J Invest Dermatol. 1952;19:101–102. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials